Our Collaborations
Explore how Gilead collaborates and partners with the National Health Service and other healthcare and patient organisations across the UK and Ireland to improve the care of a variety of patient groups.
HIV
Gay Men’s Sexual Health Survey
Status: Ongoing
This survey of gay and bisexual men and other men who have sex with men in London is a collaboration between Gilead and University College London. This survey aims to measure the prevalence of undiagnosed HIV and exploring HIV & sexually transmitted infection (STI) prevention behaviours and attitudes in this population.
Read more about this project:
Executive Summary
HIV Lens
Status: Ongoing
HIV Lens is a digital data mapping tool that presents local, regional and national HIV data. The tool provides data to support the work of commissioners, community organisations, policy makers and others in an accessible and insightful format. HIV Lens is a collaborative project with NAM Publications and Watipa.
Read more about this project:
Executive Summary
Positive Voices
Status: Ongoing
Positive Voices survey 2022 is the second round of UK Health Security Agency’s (UKHSA) national survey of people living with HIV, which is the largest survey of people living with HIV in the UK. Gilead has collaborated with UKHSA on two specific sub-analyses, focused on people's use and experience of non-HIV health and care services.
Read more about this project:
Executive Summary
Publication:
Positive Voices 2022: survey report
The co-design of a digital health pathway of care for the delivery of the POSITIVE OUTCOMES patient reported outcome measure (PROM)
Status: Ongoing
This Joint Working Project aims to co-design and implement a digital health pathway of care for the delivery of a PROM, ensuring it is person-centred and acceptable from a patient and clinician perspective regarding user experience and flow.
Read more about this project:
Executive Summary
The digitalisation of patient pre appointment assessment and annual health review
Status: Ongoing
The project involves the North Central London (NCL) HIV Network and Gilead Sciences Ltd jointly working together to develop a digital solution to facilitate patient-reported health outcomes and clinician guided health data collection to assist clinicians to deliver more holistic care to people living with HIV.
Read more about this project:
Executive Summary
‘Get tested LeEDs’: Accident and emergency department blood-borne virus opt-out testing combined with an enhanced rapid care pathway
Status: Completed
Evaluation of real-world effectiveness and sustainability of integrated pathway for HIV, hepatitis B and C opt-out testing and linkage to care in a large urban emergency department outside London.
Read more about this project:
Executive Summary
Development of a high-level best practice process map to optimise services and care across the HIV care continuum in Liverpool
Status: Completed
Sahir House, Liverpool and Gilead Sciences Ltd are undertaking this collaborative working project with the aim of optimising HIV services and care in Liverpool.
Read more about this project:
Executive Summary
Exploration of The Effective Management of Complex HIV Clinical Care (ageing and co-morbidities) with Digital Technology
Status: Completed
This project concept was to explore the possibilities of how digital solutions may improve the care of people living with HIV in early frailty and/or with co-morbidities.
Read more about this project:
Executive Summary
London Initiative for Glandular fever HIV Testing (LIGHT)
Status: Completed
Real-word evaluation of effectiveness and sustainability of the addition of HIV test assays in primary care laboratory mononucleosis screens to detect primary HIV infection.
Read more about this project:
Executive summary
CAR-T
Initiating a Patient-Centric CAR-T Service
Status: Ongoing
This collaborative working project between Gilead Sciences Ltd and Western General Hospital, Edinburgh, will provide dedicated resources to a patient-centric CAR T service. It will include setting up a nurse/pharmacy-led clinic, introduce consistent educational programmes for health care professionals, and implement a holistic needs assessment approach to improve the overall patient experience.
Read more about this project:
Executive Summary
The CAR-T Simulation Course
Status: Ongoing
This project aims to make available a new iteration of a simulation training program developed by St. George’s Hospital to provide clinicians with practical experience in familiarising themselves with CAR-T patient counselling and management in a mock (simulated) environment.
Read more about this project:
Executive Summary
Advanced Therapy Treatment Centres (ATTC) Network: CAR-T Patient Referrals Pathway Gap Analysis
Status: Completed
The Cell and Gene Therapy Catapult & The ATTC Network developed a report to analyse CAR-T patient referral pathways & make recommendations for improvements. These reforms will help to ensure that pathways remain fit for the next 5 years of CAR-T therapy and deliver equitable access to patients.
Read more about this project:
Executive Summary
Publication:
Future-proofing the UK CAR-T patient referral pathway
Liver
Hep CU Later - Hepatitis C patient Identification Collaboration
Status: Ongoing
This project aims to micro-eliminate hepatitis C in all drug and alcohol services across NHS Trusts which are part of the NHS Addictions Provider Alliance and to expand benefits across the wider UK region by sharing the considerable expertise that has been built by Hep CU Later and Gilead Sciences Ltd.
Read more about this project:
Executive Summary
STEP-C Free: Support to Treatment by Engagement with Peers = Hep C Free
Status: Ongoing
A Joint Working Project between NHS-Forth-Valley (NHSFV) and Gilead Sciences Ltd. aims to support the Scottish Government's target of hepatitis C elimination by 2025.
Read more about this project:
Executive Summary
NHS Substance Misuse Alliance: Hepatitis C Patient Identification
Status: Completed
This initiative is led by the NHS Addictions Provider Alliance (formally the NHS Substance Misuse Alliance) and is a Joint Working agreement with Gilead Sciences Ltd. The aim is to micro-eliminate hepatitis C within the drug and alcohol services of the NHS Addictions Provider Alliance.
Read more about this project:
Impact Report - Year 1
Impact Report - Year 2
Emergency department unlinked anonymous blood-borne virus (BBV) seroprevalence - ‘ENABLE’
Status: Completed
Multicentre unlinked anonymous testing BBV prevalence survey in three urban emergency departments to inform epidemiology and public health resource allocation.
Read more about this project:
Executive Summary
Publication:
Consistent high prevalence of undiagnosed blood‐borne virus infection in patients attending large urban emergency departments in England
Real-world clinical effectiveness and sustainability of universal bloodborne virus testing in an urban emergency department in the UK
Peer based hepatitis C patient finding
Status: Completed
This project aimed to engage with people with lived experience of addiction and/or blood-borne viruses in outer central Glasgow, by creating a community-based, peer-led hepatitis C outreach programme in partnership with the Hepatitis C Trust and Bluevale Community Club.
Read more about this project:
Executive Summary
VirA+EmiC: Accident and emergency department hepatitis B and C opt-out testing combined with an enhanced rapid care pathway
Status: Completed
Evaluation of real-world effectiveness and sustainability of integrated pathway for hepatitis B and C opt- out testing and linkage to care in a large urban emergency department in London.
Read more about this project:
Executive Summary